Cardiovascular Research

Formed in March 2004, the Stanford Cardiovascular Institute (SCVI) is a unique center for cardiovascular disease research and treatment.

At the nucleus of SCVI is a richly diverse group of 178 University faculty scientists, scholars, engineers and adult and pediatric clinicians whose multidisciplinary collaborations will focus on the prevention, treatment, and ultimate elimination of cardiovascular diseases.

SCVI is one of four institutes established by Stanford School of Medicine to be the pillars of its future interdisciplinary efforts in understanding, preventing and treating human disease.

The Stanford Cardiovascular Institute will:

  • Develop and pioneer integrative strategies to prevent, treat and ultimately cure heart disease
  • Advance the frontiers of cardiovascular medicine
  • Translate the extraordinary progress of science and technology into new applications
  • Promote heart health

Our Doctors

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

For Health Care Professionals

You may make referrals to Stanford with confidence, knowing that your request will be handled immediately and that most of your patients will be admitted for evaluation within 24 to 48 hours.

Referral to Cardiovascular Medicine
Phone: 650-723-6459

Referral to Cardiovascular Surgery:
Phone: 650-724-7500

Referral to Heart Failure & Cardiomyopathy and Heart Transplant Evaluation:
Contact: Valerie Cannon
Phone: 650-723-5468

Track your patients' progress and communicate with Stanford providers securely online.

Learn More About PRISM »